Cytotoxic agents comprising new C-2 modified taxanes

Details for Australian Patent Application No. 2005313445 (hide)

International Classifications

Event Publications

19 July 2007 PCT application entered the National Phase

PCT publication WO2006/061259 Priority application(s): WO2006/061259

28 February 2008 Amendment Made

The nature of the amendment is: Delete co-inventor Commercom, Alain

10 April 2008 Assignment before Grant

Aventis Pharma S.A. The application has been assigned to ImmunoGen, Inc.

3 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.